The Economic Times
Sanofi-backed Formation Bio raises $372 million in late-stage funding round - ET HealthWorld | Pharma
London: AI-based drug developer Formation Bio said on Wednesday that it has raised $372 million in a late-stage funding round, with a significant participation from French drugmaker
3 days ago
Clinical Trials Arena
Sanofi reports data from Phase II demyelinating polyneuropathy trial
4 days ago
Sanofi reports positive data from Phase III EoE treatment trial
Pharmaceutical Technology
Pharma M&A: The top high value deals in 2023
Lilly joins fellow pharma giants in OpenAI partnership
BioPharma Dive
PTC faces another Duchenne drug rejection; Coherus sells Humira biosimilar
2 days ago
View all
French pharmaceutical company
sanofi.com
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. Wikipedia
Stock price: SNY (NasdaqGS) $48.52 +0.44 (+0.92%)
Fri, Jun 28, 2024, 4:00PM EDT